| 1 |
Kouladouros K, Hirth M. Palliative endoskopische Therapie bei Klatskin-Tumoren. Onkologie up2date 2022;4:161-178. [DOI: 10.1055/a-1756-1159] [Reference Citation Analysis]
|
| 2 |
Song S, Gong S, Lei T, Tian H, Lu T, Lei C, Jin H, Yang W, Yang K, Guo T. Comparative efficacy and safety of local palliative therapeutics for unresectable malignant biliary obstruction: a Bayesian network meta-analysis. Expert Rev Gastroenterol Hepatol 2022;16:555-67. [PMID: 35639826 DOI: 10.1080/17474124.2022.2085090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 3 |
Tzedakis S, Sindayigaya R, Dhote A, Marchese U, Barret M, Belle A, Coriat R, Barat M, Soyer P, Fuks D. Perihilar cholangiocarcinoma: What the radiologist needs to know. Diagnostic and Interventional Imaging 2022. [DOI: 10.1016/j.diii.2022.03.001] [Reference Citation Analysis]
|
| 4 |
Ivanusa SY, Alentev SA, Evstrateva DY, Molchanov AA. Locoregional methods of treatment of patients with extrahepatic bile duct cholangiocarcinoma (review of literature). VESTNIK KHIRURGII IMENI I I GREKOVA 2021;180:111-117. [DOI: 10.24884/0042-4625-2021-180-5-111-117] [Reference Citation Analysis]
|
| 5 |
Kouladouros K, Hirth M. Palliative endoskopische Therapie bei Klatskin-Tumoren. Allgemein- und Viszeralchirurgie up2date 2021;15:307-322. [DOI: 10.1055/a-1317-3509] [Reference Citation Analysis]
|
| 6 |
Sukumar V, Patkar S, Goel M, Sahay A. Intrahepatic Cholangiocarcinoma Presenting as a Scalp Mass. J Gastrointest Cancer 2020;51:1044-6. [PMID: 32152822 DOI: 10.1007/s12029-020-00388-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Rahnemai-Azar AA, Abbasi A, Tsilimigras DI, Weber SM, Pawlik TM. Current Advances in Minimally Invasive Surgical Management of Perihilar Cholangiocarcinoma. J Gastrointest Surg 2020;24:2143-9. [PMID: 32410178 DOI: 10.1007/s11605-020-04639-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Kim Y, Jang SI, Lee DK. SEMS Insertion for Malignant Hilar Stricture: ERCP Versus the Percutaneous Approach. Advanced ERCP for Complicated and Refractory Biliary and Pancreatic Diseases 2020. [DOI: 10.1007/978-981-13-0608-2_7] [Reference Citation Analysis]
|
| 9 |
Tringali A. Endoscopic Management in Malignant Biliary Strictures: Tips and Tricks. Endotherapy in Biliopancreatic Diseases: ERCP Meets EUS 2020. [DOI: 10.1007/978-3-030-42569-2_40] [Reference Citation Analysis]
|
| 10 |
Prasoon P, Miura K, Yuza K, Hirose Y, Sakata J, Wakai T. Perihilar or (Hilar) Cholangiocarcinoma: Interventional to Surgical Management. Bile Duct Cancer 2019. [DOI: 10.5772/intechopen.82113] [Reference Citation Analysis]
|
| 11 |
Bokemeyer A, Matern P, Bettenworth D, Cordes F, Nowacki TM, Heinzow H, Kabar I, Schmidt H, Ullerich H, Lenze F. Endoscopic Radiofrequency Ablation Prolongs Survival of Patients with Unresectable Hilar Cholangiocellular Carcinoma - A Case-Control Study.Sci Rep. 2019;9:13685. [PMID: 31548703 DOI: 10.1038/s41598-019-50132-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 12 |
O'Brien S, Bhutiani N, Egger ME, Brown AN, Weaver KH, Kline D, Kelly LR, Scoggins CR, Martin RCG 2nd, Vitale GC. Comparing the efficacy of initial percutaneous transhepatic biliary drainage and endoscopic retrograde cholangiopancreatography with stenting for relief of biliary obstruction in unresectable cholangiocarcinoma. Surg Endosc 2020;34:1186-90. [PMID: 31139984 DOI: 10.1007/s00464-019-06871-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Gurmikov BN, Kovalenko YA, Vishnevsky VA, Chzhao AV. Intrahepatic cholangiocellular carcinoma: diagnosis and treatment (review). Ann hir gepatol 2019;23:108-117. [DOI: 10.16931/1995-5464.20184108-117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 14 |
Singla A, Kozarek RA. Hilar Malignant Strictures. Advanced Therapeutic Endoscopy for Pancreatico-Biliary Diseases 2019. [DOI: 10.1007/978-4-431-56009-8_26] [Reference Citation Analysis]
|
| 15 |
Martin EK, Bhutiani N, Egger ME, Philips P, Scoggins CR, McMasters KM, Kelly LR, Vitale GC, Martin RCG. Safety and efficacy of irreversible electroporation in the treatment of obstructive jaundice in advanced hilar cholangiocarcinoma. HPB (Oxford) 2018;20:1092-7. [PMID: 30057125 DOI: 10.1016/j.hpb.2018.06.1806] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 16 |
Khuntikeo N, Titapun A, Loilome W, Yongvanit P, Thinkhamrop B, Chamadol N, Boonmars T, Nethanomsak T, Andrews RH, Petney TN, Sithithaworn P. Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia. Front Med (Lausanne) 2018;5:117. [PMID: 29765958 DOI: 10.3389/fmed.2018.00117] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 17 |
Wan X, Chen S, Zhao Q, Li T, Luo S, Cai X, Ren Y, Yu L, Li B. The efficacy of temporary placement of nasobiliary drainage following endoscopic metal stenting to prevent post-ERCP cholangitis in patients with cholangiocarcinoma. Saudi J Gastroenterol 2018;24:348-54. [PMID: 30027911 DOI: 10.4103/sjg.SJG_94_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 18 |
Roll GR, Roberts JP. Surgical Options in Liver Cancers. Schiff's Diseases of the Liver 2017. [DOI: 10.1002/9781119251316.ch37] [Reference Citation Analysis]
|
| 19 |
Buettner S, van Vugt JL, IJzermans JN, Groot Koerkamp B. Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther. 2017;10:1131-1142. [PMID: 28260927 DOI: 10.2147/ott.s93629] [Cited by in Crossref: 84] [Cited by in F6Publishing: 91] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 20 |
Xu B, Xu M, Tian Y, Yu Q, Zhao Y, Chen X, Mi P, Cao H, Zhang B, Song G, Zhan YY, Hu T. Matrine induces RIP3-dependent necroptosis in cholangiocarcinoma cells. Cell Death Discov 2017;3:16096. [PMID: 28179994 DOI: 10.1038/cddiscovery.2016.96] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 21 |
Buettner S, Wilson A, Margonis GA, Gani F, Ethun CG, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM. Assessing Trends in Palliative Surgery for Extrahepatic Biliary Malignancies: A 15-Year Multicenter Study. J Gastrointest Surg 2016;20:1444-52. [PMID: 27121233 DOI: 10.1007/s11605-016-3155-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 22 |
Park YK, Choi JE, Jung WY, Song SK, Lee JI, Chung CW. Mucosa-associated lymphoid tissue (MALT) lymphoma as an unusual cause of malignant hilar biliary stricture: a case report with literature review. World J Surg Oncol 2016;14:167. [PMID: 27343073 DOI: 10.1186/s12957-016-0928-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 23 |
Chen Y, Li H, Jiang X, Chen D, Ni J, Sun H, Luo J, Yao H, Xu L. Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study.Eur Radiol. 2016;26:3500-3509. [PMID: 26822373 DOI: 10.1007/s00330-016-4208-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 24 |
Moole H, Dharmapuri S, Duvvuri A, Dharmapuri S, Boddireddy R, Moole V, Yedama P, Bondalapati N, Uppu A, Yerasi C. Endoscopic versus Percutaneous Biliary Drainage in Palliation of Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic Review. Can J Gastroenterol Hepatol 2016;2016:4726078. [PMID: 27648439 DOI: 10.1155/2016/4726078] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 25 |
Hammad AY, Berger NG, Gamblin TC. Point-of-Care Clinical Guide: Cholangiocarcinoma. Pancreas and Biliary Disease 2016. [DOI: 10.1007/978-3-319-28089-9_13] [Reference Citation Analysis]
|
| 26 |
Smith I, Kahaleh M. Biliary Tumor Ablation with Photodynamic Therapy and Radiofrequency Ablation. Gastrointest Endosc Clin N Am 2015;25:793-804. [PMID: 26431605 DOI: 10.1016/j.giec.2015.06.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 27 |
Zhang H, Zhu J, Ke F, Weng M, Wu X, Li M, Quan Z, Liu Y, Zhang Y, Gong W. Radiological Imaging for Assessing the Respectability of Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Biomed Res Int. 2015;2015:497942. [PMID: 26448940 DOI: 10.1155/2015/497942] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 28 |
Mangiavillano B, Pagano N, Baron TH, Luigiano C. Outcome of stenting in biliary and pancreatic benign and malignant diseases: A comprehensive review. World J Gastroenterol 2015; 21(30): 9038-9054 [PMID: 26290631 DOI: 10.3748/wjg.v21.i30.9038] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 29 |
Jang SI, Lee DK. Update on Pancreatobiliary Stents: Stent Placement in Advanced Hilar Tumors. Clin Endosc 2015;48:201-8. [PMID: 26064819 DOI: 10.5946/ce.2015.48.3.201] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 30 |
Melenhorst MC, Scheffer HJ, Vroomen LG, Kazemier G, van den Tol MP, Meijerink MR. Percutaneous Irreversible Electroporation of Unresectable Hilar Cholangiocarcinoma (Klatskin Tumor): A Case Report. Cardiovasc Intervent Radiol. 2016;39:117-121. [PMID: 25994516 DOI: 10.1007/s00270-015-1126-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 31 |
朱 学. Typing, Risk Factors and Related Treatments of Cholangiocarcinoma. ACM 2014;04:74-80. [DOI: 10.12677/acm.2014.44014] [Reference Citation Analysis]
|
